Literature DB >> 1493625

The histopathology of mastoidectomy cavities, with particular reference to persistent disease leading to chronic otorrhoea.

R Youngs1.   

Abstract

Open cavity mastoidectomy remains the principal surgical treatment of middle ear cholesteatoma in the United Kingdom. A significant proportion of mastoid cavities are prone to intermittent or continuous discharge. In this study the histopathological features of material removed from 159 mastoid cavities at revision surgery were reviewed. Findings included squamous epithelium with acute and chronic inflammation, foreign body granuloma and aural polyps. Of particular note was the very infrequent finding of discharging cavities lined with respiratory epithelium, suggesting that retained mucosa in mastoid air cells is not a common cause of persistent otorrhoea.

Entities:  

Mesh:

Year:  1992        PMID: 1493625     DOI: 10.1111/j.1365-2273.1992.tb01706.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  4 in total

Review 1.  Idiopathic, Infectious and Reactive Lesions of the Ear and Temporal Bone.

Authors:  Kelly R Magliocca; Esther X Vivas; Christopher C Griffith
Journal:  Head Neck Pathol       Date:  2018-08-01

2.  Histopathological and Inflammatory Features of Chronically Discharging Open Mastoid Cavities: Secondary Analysis of a Randomized Clinical Trial.

Authors:  Darius Henatsch; Sultan Alsulami; Adriaan M Duijvestijn; Jack P Cleutjens; Carine J Peutz-Kootstra; Robert J Stokroos
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-03-01       Impact factor: 6.223

3.  Mastoid obliteration and external auditory canal reconstruction with silicone block in canal wall down mastoidectomy.

Authors:  Mohammad Faramarzi; Reza Kaboodkhani; Ali Faramarzi; Sareh Roosta; Mohammadjavad Erfanizadeh; Milad Hosseinialhashemi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-27

4.  Canal wall down mastoidectomy: A long term commitment to the outpatients?

Authors:  Hisham S Khalil; Paul C Windle-Taylor
Journal:  BMC Ear Nose Throat Disord       Date:  2003-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.